LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma

Published:2024-03 Issue:3 Volume:300 Page:105762
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Liu Chang,Zhao Xinan,Wang Zifeng,Zhang Chan,Zheng Wenbin,Zhu Xiaoxia,Zhang Dong,Gong Tao,Zhao Hong,Li Feng,Guan Tao,Guo Xiangyang,Zhang Hongwei^ORCID,Yu Baofeng

Funder

Shanxi Province Natural Science Foundation

Publisher

Elsevier BV

Reference49 articles.

1. Limited-stage diffuse large B-cell lymphoma;Hawkes;Blood,2022

2. International prognostic indices in diffuse large B-cell lymphoma (DLBCL): a comparison of IPI, RIPI and NCCN-IPI;Ruppert;Blood,2020

3. Super-enhancer hypermutation alters oncogene expression in B cell lymphoma;Bal;Nature,2022

4. Smart start: rituximab, lenalidomide, and ibrutinib in patients with newly diagnosed large B-cell lymphoma;Westin;J. Clin. Oncol.,2023

5. Patient parameters and response after administration of rituximab in pediatric mature B-cell non-Hodgkin lymphoma;Bethke;Pediatr. Blood Cancer,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photosensitive Nanoprobes for Rapid High Purity Isolation and Size‐Specific Enrichment of Synthetic and Extracellular Vesicle Subpopulations;Advanced Functional Materials;2024-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP